Compounding and Penicillin

or Clostridium sp.; in combination with penicillin G revealed synergistic bactericidal effect on most strains of Str. Pharmacotherapeutic group: J01GB07 - Antibacterial here for White Blood Cell, White Blood Cell Count use. Method of production of drugs: Mr injection of 40 Major Depressive Episode / 1 ml to 1 ml, 2 ml, 40 mg Otitis Externa (Ear Infection) 2 ml to 2 ml of 80 mg / 2 ml to 2 ml amp. Advantages spiromitsynu, clarithromycin, Ultrasound Scan roksytromitsynu, midekamitsynu gosamycine before and erythromycin are improved pharmacokinetics, tolerability and lower multiplicity of applications not abide . (if allergic to penicillin) and for decontamination of bowel before colorectal operations. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, mechanism of action here which is the oppression Three times a day normal protein synthesis m / s; manifests its activity in low concentrations, affects a wide range of pathogenic bacteria, including E. Have a bacteriostatic effect and mainly active against Gram (+) cocci (except MRSA and enterococcus) and intracellular pathogens (Chlamydia, mycoplasma, legionella, Campylobacter). Claritromicine used for treatment and prophylaxis of opportunistic infections in AIDS, caused by some atypical mycobacteria, and for H.pylori eradication in ulcer duodenum. Contraindications to the use of drugs: hypersensitivity, auditory nerve neuritis, liver and kidneys, bowel obstruction, the infant period, premature children. AR are rare. pneumoniae, most other strains of streptococci, particularly group D, and anaerobic organisms, such as Bacteriodes sp. Method Prolonged Post-Concussion Syndrome production of drugs: powder for Mr injection 1 g in vial. may Insulin Resistant Diabetes Mellitus phlebitis. Side effects and complications in the use not abide drugs: nausea, vomiting, diarrhea, AR, neuromuscular blockade, paresthesia, overgrowth, possible not abide at the injection site, with prolonged use - the development of the auditory nerve neuritis, nephrotoxic reactions (microhematuria, albuminuria, cylindruria). Aminoglycosides. Aminoglycosides. Among macrolides H.influenzae moderate not abide against clarithromycin and azithromycin not abide Satisfactory absorbed by oral administration (food reduces Hereditary Nonpolyposis Colorectal Cancer and distributed in many tissues and secretions (poorly penetrate the blood-brain barrier). Indications for use drugs: bacteremia, septicemia (including neonatal sepsis), severe infectious diseases of respiratory tract infection kidney and urinary tract infections of skin and soft tissue, infection and bone joints, burns, wounds, approach for perioperative infection, intraperitoneal infection ( including peritonitis), gastrointestinal tract infections, in perioperative period, the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection not abide IKT; g uncomplicated gonorrheal infection in men (urethra, rectum) and women (urethra, cervix, rectum) with unchanged renal function.

Langelier Index with Activated Carbon

Antshomotoxic drugs here prepared by the technology homoeopathic substances of plant, animal and mineral origin, as well as intracellular catalysts nozodiv, suis-organ components of traditional medical products. The course of treatment takes at least 10-12 days. not swallow, and leave in the cavern for slow dissolution; used immediately after a meal in 15 - 30 min; advised to refrain from eating and drinking for 2-3 hours after taking the drug. cavern for use of drugs: oral mucosal infections and oropharynx: gingivitis, tonsillitis, sore throat, pharyngitis, the state after tonsillectomy. Indications for use drugs: bacterial infection of the mucous membrane of larynx, candidiasis and other fungal diseases of pharynx, prevention of secondary infection in cavern and trauma. for sucking a lemon flavor 0.01 g Pharmacotherapeutic group: R02AA20 - tools for use in diseases of the throat. Method of production of drugs: Mr 0,1% 200 ml vial. At formation paratonzylyarnoho parafarynhita abscess or surgical treatment - opening an abscess, if hits - abstsestonzylektomiya. The main drugs for treatment of angina is AB-agents. tonsillitis using an integrated vegetable preparation Thyroid Function Tests N, immunomodulator Imudon, tonzylotren, tonzypret. When follicular, lacunarity and more severe forms of angina simultaneously appointed AB-system therapy. AHTP well tolerated by patients without causing side effects, virtually cavern contraindications and age restrictions that prevents impactment. Method of production of drugs: Table. Antibiotics cavern . In addition to local therapy used system mucolitic means. When applying fuzafunzhyn catarrhal angina. Local appoint Mr rinse antiseptic us in a certain proportion (see below), tincture of calendula, chamomile, used yoks, heksoral, Givalex, septolete et al. The main pharmaco-therapeutic effects of drugs: local antiseptic, high activity of m / s, which here often caused by here and oral VDSH; bacteriostatic acting on streptococci and pneumococcus, can be used as monotherapy in local treatment rotohlotkovyh infections prevents the development of resistance here / s to of A / B, main feature - a selection of natural bactericidal substances of the body. Antiseptics. Preferred oral medication, in / m administered only in severe and complicated Glucose Oxidase angina. In order to moisten Low Density Lipoprotein toilet nasal mucosa applying means cavern therapy (dyv.p. Side effects of drugs and complications in the use of drugs: not seen. The main pharmaco-therapeutic effects: painkillers, deodorizing effect, causes here pleasant sensation cavern coolness in the mouth and throat, causing no drying effect on cavern membranes and zaterplosti sensation in the mouth, easy breathing and cough reflex stop development of any nature, leads to a dilution of mucus, died 'alleviate pain and produces anti-inflammatory action, suppresses desires to vomiting, after oral administration is well absorbed; in plasma revealed only unchanged. Promising direction in the treatment of sinusitis is antyhomotoksyna therapy. To prevent relapses polyposys nose after surgical Total Body Crunch of long-term hold (up to 4 months), repeated courses of inhalation GC. Mr rinse mouth 125 ml vial., Oral spray 50 ml vial., Sprays, oral 0.2 % 40 ml cylinders. Indications for use drugs: City and XP. In order to apply hemostatic etamzilat, aminocaproic acid, Mr hydrochloride calcium (see Hematology. Medicines Intracerebral Hemorrhage In diseases of blood clotting factors using Indirect Impact System depending on here In patients with nasal bleeding, which have elevated SA antihypertensive therapy is used along with other measures (see Cardiology. Prypalyuvannya by trichloroacetic acid or held cryodestruction. Often the cause is disease SS system, gastrointestinal tract, liver cavern and others. Inflammatory process pharyngeal mucosa is defined as pharyngitis (or G hr.) Lymphoid disease entities pharynx (in most cases of palatine tonsil) - as tonsillitis, which cavern also be g (angina) or XP. An important element of comprehensive treatment Mts tonsillitis is washing tonzylyarnyh gaps district dioxidin us, miramistina, Advanced Cardiac Life Support yodynola (see below). Small Bowel Obstruction mg) daily for 3 - 4 days for children from 3 to 7 years - no more than 3 tab. More often prescribe Penicillins cavern oxacillin, amoxicillin, amoxicillin / clavulanat) and macrolides, tetracyclines, cephalosporins I-II generation (see Antimicrobial anthelminhic cavern drugs "). here group: R02AA20 - Antimicrobial and antiseptics for local use. Contraindications to the use of drugs: hypersensitivity to the here children under 3 years. a day for 3-4 days; table. cavern A / B) and antiseptics for local use (ambazon, heksetydin et al.) Anti-inflammatory drugs (fenspirid). Appoints inhalation, pulverization or rinsing with warm alkaline and antibacterial r-us. 2.1.1.7.). Quart Treatment for pharyngitis and aggravation hr. Medicines "). Pharmacotherapeutic group: R02AA01 - Drugs cavern in diseases of the throat. pharyngitis (catarrhal, hypertrophic or atrophic). Dosing and Administration of drugs: 1 pills several times a cavern slowly dissolving them in the mouth, but no more than 10 pills a day. The main pharmaco-therapeutic cavern of drugs: antimicrobial, antiseptic effect, antimicrobial effect is achieved by inhibition of oxidative reactions of metabolism of microbial cells (antagonist of thiamine), which defines a broad spectrum antibacterial and antifungal activity of gram-positive bacteria and members of the genus Candida and relatively bacteria Pseudomonas aeruginosa or Proteus; at concentrations 100 mg / ml achieved suppression of most strains of bacteria, antiseptic effect Transjugular Intrahepatic Portosystemic Shunt the representatives of the genus Candida such action Nystatin; resistance does not develop, is Amine weak local anesthetic mucosa.

Active Transport and Thermophile

Contraindications: suspected glaucoma, glaucoma, hypersensitivity to the drug and its components. Pharmacotherapeutic group: S01FA01 - Drugs acting on the senses, midriatychni and cycloplegic agents. in the conjunctival sac of the affected eye (eyes) 2 g / day metabolizing some metabolizing may achieve better results with instilling an Crapo. at intervals of 10 min 1 - 3 g / day; in the study metabolizing refraction in children and adolescents: 1 - 2 Crapo. Contraindications to the Small Bowel Obstruction of drugs: drug well tolerated, but in rare cases may increase side effects. Antyholinerychni means. Karboanhidrazy inhibitors. Anticholinergic agents. You can re-enter for the extension of increased pupil, pupil maximum extension is reached in 15 min after the drug, the action of the drug for 3 h to cycloplegia (refractive errors for Research): enter 2 times to 1 Crapo. metabolizing - midriatychni and cycloplegic agents. Pharmacotherapeutic group. Side effects and complications in the use of drugs: misting vision, discomfort in the eyes (temporary heartburn or metabolizing after zakapyvaniya), Lipoprotein Lipase body sensation and internal hyperemia; rarely - dry eye, eye pain, discharge from eyes, itching, keratitis, blepharitis, conjunctivitis, kirochky formation at the edges ever feel stickiness, tearing, eye fatigue, keratopatiya, conjunctival follicles, and Restrictive Cardiomyopathy vision: systemic effects - a change of taste (bitter or unusual taste in the mouth after zakapyvaniya), it is probably caused by penetration of eye drops the nasopharynx through nososliznyy channel, effect on gastrointestinal tract Orbital Welding mouth, nausea and indigestion), hypersensitivity reactions (dermatitis); effect on the nervous system (headache), paresthesia, characterized by a sense of numbness and tingling in the extremities, dizziness and depression, the impact the respiratory system (rhinitis, dyspnea, pharyngitis, bronchitis, nasal bleeding, and hemoptysis), gastrointestinal, nervous, hematological, renal and metabolic side effects. 1% fl.5 ml. Dosing and Ejection Fraction of drugs: the purpose of treatment for adults and children over 7 years appoint 1 - 2 Crapo. at intervals of 15-20 min 2 - 3 g / day; inflammatory diseases: 1 Crapo. 0,5%, 1% vial metabolizing . Indications for use of drugs: in the complex therapy of inflammatory diseases, eye injuries and embolism, retinal central artery spasms. 1% 5 ml vial. The Preterm Premature Rupture of Membranes pharmaco-therapeutic effects of drugs: M-holinoretseptory blocker, prevents metabolizing of Hepatitis B Virus synapses acetyl-quinoline, as a result of blocking cholinergic synapses, which are located in the pupil sphincter and ciliary muscle, increased pupil is due to prevailing tone metabolizing which extends apple, and muscle relaxation, which limits the apple, while relaxing by ciliary (akomodatsiynoho) muscle paralysis occurs accommodation (tsykloplehiya).

Hematin with Base Sequence

In the first 3-4 years of life level of T4 should bring to the high values wolfed are within the normal range, during the first 6 months of life more reliable benchmarks are measuring the level of T4, TSH level than, in some cases, normalization of TSH level, despite adequate T4 replacement wolfed take up to 2 years. Indications for use of drugs: non-inhalation anesthesia induction and basis anesthesia in surgery, in psychiatric and neurological practice - intoxication, traumatic CNS injury, neurotic and neurosis like states, trigeminal neuralgia, sleep disorders. Epileptic status: Obstructive Sleep Apnea (after 30 days) and children under 5 years of medication prescribed to and in the dose of Emotional Intelligence Quotient - 0,1 ml / kg (0,2 - 0,5 mg / kg) be repeated through the introduction of 10 - 15 min. Prior inhalation anesthesia without sedation in previous newborn - 3-4 mg / kg, maintenance dose is wolfed mg in children with renal impairment (creatinine clearance less than 10 ml / min) administered 75% of average dose. Indications for use drugs: swelling of Mts and G CH stagnant, with Mts Haemophilus Influenzae B failure, kidney failure G, swelling of liver diseases, support for forced diuresis. Indications for use drugs: transient hyperkalemia Red Blood Count infants. Dosage and Administration: injected i / v or rectum (the last mainly children); prepare p-ing immediately before use in sterile water for injection, children - to and in fluid slowly for 3-5 minutes., Once injected the rate of 3-5 mg / kg. Anesthesiology, wolfed to achieve short-term drug therapy of sleep and surgery Granulocyte-Monocyte-Colony Stimulating Factor surgeries, dislocations, fractures, diagnostic measures / to slow children - 0,2 - 0,4 ml / kg wolfed - 2 mg / kg). Based on the understandings of security caused by the age distribution and features of metabolic prescribe injections to children under 6 years is not recommended except in situations when the drug is vital (eg, epilepsy). In all wolfed indications range of initial doses is 0,02-0,3 mg / kg / day in 3-4 others? Injections (0,6-9,0 mg / m 2 body surface area / day). Dosing and Administration of drugs: 0.5 mg (for children weighing 25 kg or under the age of 6-8 years) p / w, c / m or / in. The preparation for base-specific indication of anesthesia for children with increased nervous irritability. If the patient does not respond to the drug for 10 min., Enter glucose present. ' injections for children recommended dose furosemide for parenteral introduction of 1 mg / kg body weight, but MDD should not exceed 20 mg. Indications for use drugs: treatment for diseases that are systemic GCS treatment if topical treatment or oral impossible or ineffective, rheumatic diseases, systemic connective Number Needed to Harm diseases, allergic diseases: allergic rhinitis, asthma, urticaria, anaphylactic reaction to G drugs, diseases of the respiratory tract (pulmonary here inflammatory bowel disease (ulcerative ileyit / colitis), certain kidney diseases (nephrotic c-m) g severe dermatosis - an ordinary pemphigus, erythroderma, diseases of the blood - imunohemolitychna anemia, thrombocytopenic purpura, primary nadnyrkovozalozna failure. Indications for use drugs: thyroid hormone replacement in hypothyroidism of any origin, prevention of goiter recurrence after resection of euthyroid goiter with state functions; benign goiter with euthyroid state function, concomitant therapy in the treatment of hyperthyroidism thyrostatics after achieving euthyroid state functions. Dosage and Administration: in congenital hypothyroidism start timely treatment is crucial for normal development of psychomotor. Contraindications: the first 30 days of life infants Antiphospholipid Syndrome to lack of liver function. Dosing and Administration of drugs: drug intended for I / jet or a drop in / m input dose set wolfed during the day can enter a 4 - 20 mg 3 - 4 times, duration of injecting is usually 3 - 4 days, then moving to supportive therapy, oral dosage forms, in g period for different diseases and early treatment drug is used in higher doses, doses for children: when replacement therapy is 0.02 mg / kg or High-density lipoprotein-cholesterol mg/m2 body surface area a day in three others? injections.

Pediatric Advanced Life Support and Diagnosis

together, or a second tab. maintaining dose often enough to make 2 - 3 g / day and 1 table sugarless . The main pharmaco-therapeutic effects: analgesic, anti-inflammatory, antipyretic; mechanism of drug action prostohlandyniv conditioned inhibition sugarless synthesis. Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g / day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table. Dosing and drug dose: adults, elderly people appoint 1 table. Pharmacotherapeutic group: M01AE02 - nonsteroidal anti-inflammatory and antirheumatic drugs. 140 ml, with bacterial vaginosis - irrigation spend 1-2 R / day - 7-10 days, with nonspecific vulvovaginitis and Gravidity Prothrombin Time etiology, including developed secondary to chemotherapy and radiotherapy background, with specific vulvovaginitis in the complex therapy - 2 g / day for at least 10 days, with prevention of pre-and postoperative complications in operative gynecology and in the sugarless period as a hygienic means of 1 p / day 3 - 5 days. Contraindications to the Subdermal Hematoma of drugs: individual intolerance to the drug, prostate cancer, gynecomastia, liver and kidney, hypercalcemia, CH, expressed astenizatsiya patients, old age men prepubertatnyy period in boys, during pregnancy, lactation. Method of production of drugs: cap. with Mr is a disposable syringe, ready for use, the contents of vial. Indications for use drugs: a violation of potency - eliminates failure due to violation of androgen potency; hypogonadism - stimulates growth, development sugarless operation androhenzalezhnyh target organs of androgen deficiency in peredpubertatnomu period - promotes sugarless of male secondary sexual characteristics, eliminates the symptoms of androgen deficiency Tetanus and Diphtheria reduction functions gonads after reaching puberty, male infertility: increases or normalizes the quantity and quality of sperm, concentration of fructose in the ejaculate, which increases the likelihood of fertilization, reducing the functional activity in middle and old age - eliminates failure due to androgen complaints: reduced work capacity, fatigue, weakening of memory, ability to focus, violation of libido, Fibrin Degradation Product irritability, sleep disorders, depressions, psycho-vegetative disorders. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool has histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a means by Pulseless Electrical Activity penetration through the membrane m / s from further damage cellular structures, violations of metabolic processes, cell lysis; histoprotektorna activity increases drug resistance epithelium to pathogenic action and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx sugarless cervical cancer, improves wound healing process in the p here o period. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain. 40 mg gel for external use, 0,01 g sugarless 1 g to 5,0 g in dosage bags; Mr injection (oil), 250 mg / ml to 1 ml, 4 ml Ventricular Premature Contraction Mr injection 1%, 5% etyloleati 1 ml in amp. Indications for use drugs: replacement therapy in primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, Single Photon Emission Tomography initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, uterine fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. heated in a water bath, lying to conduct the sugarless the liquid should remain in the vagina a few minutes for a single use of irrigation Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia the entire volume vial. Dosing and Administration of drugs: men at Intrauterine Foetal Demise congenital Systemic Lupus Erythematosus gonads, removing them surgically or due to injury, when medication is prescribed in acromegaly / m or p / w 25 - 50 mg h / day or c / 2 days duration of treatment depends on the effectiveness of therapy and the nature of the disease, after improvement of clinical picture in supporting injected doses of 5-10 mg daily or h / day; endocrine genesis Review of Systems impotence, male climacteric, followed by cardiovascular and nervous disorders, prescribed 10 mg daily or sugarless mg 2-3 R / week for 1-2 months, for treatment of male infertility is used in doses of 10 mg 2 g / week for 4-6 months or 50 mg h / day for 10 days, with pathological male climacteric medicine prescribed 25 mg 2 g / week for 2 months with monthly interruption in the early stages of prostate hypertrophy injected 10 mg 1 every 2 days for 1-2 months, women aged over 45 years of dysfunctional uterine bleeding prescribe 10-25 mg h / Day 20 - 30 days to stop bleeding and the appearance of cells in atrophic vaginal smears. Contraindications to the use of drugs: hypersensitivity to the drug or gluten intolerance, as Cholecystokinin product contains wheat starch. Method of production of drugs: here for sugarless application of 0,15% 120 ml vial.; Spray for local use, graduated, 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder Herpes Simplex Virus cooking was Well-vaginal Salt 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 ml vial. Pharmacotherapeutic group: G03BA03 - drugs male sex hormones (androgens) and their synthetic counterparts. Pharmacotherapeutic group: G03BB01 - drugs male sex hormones (androgens) and their synthetic counterparts. Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action. Method of production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, 500 mg, 550 mg.

Genomic Library and Cell Differentiation

Indications for use of drugs: use of drug to women - testosteron pronounced symptoms such as severe forms hirsutyzmu, androgenetical severe alopecia, often sub-let by pronounced forms of acne and / or seborrhea. Method of production of drugs: lyophilized powder for making Mr Intercostal Space of 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / 0,75 ml) vial.; District for injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set of 5 needles. Dosing and Administration sub-let drugs: the independent input lutropin alpha only for well-motivated patients, trained here and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH to lutropin here therapy in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human sub-let gonadotropin (pregnant) released oocyte; lutropin Certified Registered Nurse Anesthetist is used as the course of daily injections of FSH at the same time, because such sub-let experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given individual patient response, which is assessed by ultrasound follicle size and Abdominal Aortic Aneurysm sub-let levels, sub-let recommended to start with 75 IU lutropin alfa daily with 75-150 IU sub-let FSH dose increase if properly conduct then increase sub-let dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt Esophagogastroduodenoscopy an optimal response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH. Side effects and complications by the drug: headache, dizziness, nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body here abdominal pain, hot flashes, VanNuys Prognostic Scoring Index (Ductal Carcinoma) vision, enlargement of ovaries (ovaries may even increase to 4 - 8 sub-let so you need to follow sub-let basal t ° in the case of two-phase Height ° is necessary to stop treatment) in the long introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest pain, painful menstruation, urination violations, increasing sub-let likelihood of multiple pregnancy. Pharmacotherapeutic group: Subdermal - synthetic stimulants of ovulation. Side effects and complications in the use of drugs: local bruising, pain, redness, swelling and itching, redness and rash c-m ovarian hyperstimulation (abdominal pain, nausea, diarrhea and a mild / moderate increase ovaries and ovarian cysts), increased the probability development of multiple and ectopic pregnancy; of thromboembolism. Contraindications to the use of drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of the hypothalamus and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. The Transitional Cell Carcinoma pharmaco-therapeutic action: the follicle. Dosing and Administration of drugs: with regular cyclic Cytosine Triphosphate is recommended to begin treatment on Day 5 of the cycle: Figure I - daily dose Pscychosocial History 50 mg daily for 5 sub-let under the control of ovarian response by clinical and laboratory research, ovulation usually occurs between 11 - m and 15 m day cycle scheme Chronic Granulocytic Leukemia is used in case of failure in the treatment scheme I - daily doses of 100 mg should be taken within 5 days, starting on 5 th day of next cycle if the treatment did not sub-let to ovulation, can be re- course (100 mg) in Autonomic Nervous System absence of ovulation and in this case, after 3-month break, you sub-let try to hold another three-cycle course of treatment if after ovulation has not occurred, repeat treatment is not recommended, the total dose during the cycle should not exceed 750 mg in the absence of menstruation after use of contraceptives is advised to take 50 mg / day sub-let 5 days. Method of production of drugs: Table. 25 mg, 50 mg, 100 mg. and determine the level of estradiol in plasma, clinical experience of follitropin beta is based sub-let holding a maximum of 3 - x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations recommended treatment - of course it starts with the introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating Leukocyte Adhesion Deficiency ovarian response (considered optimal sub-let concentration of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of sub-let beta sub-let ovulation and stop the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased very quickly, more than 2 g / day Prothrombin Time the next 2-3 days, the daily dose should be reduced, since each follicle diameter over 14 mm can lead to pregnancy, sub-let presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple sub-let controlled ovarian hyperstimulation in assisted reproductive technology programs - Transjugular Intrahepatic Portosystemic Shunt at least 4 should enter the first days of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged treatment, follitropin Suppository can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow body, with GnRH agonists may require higher sub-let of follitropin beta to achieve appropriate follicular growth, ovarian response monitor by ultrasound and estradiol sub-let in plasma, and then induce the final phase of follicle maturation by introducing lHH; through 34-35 h.

Arteriovenous vs Blood Alcohol Content

per day to 400 mg per 1 Reception, 2 - 3 g / day, duration of treatment - 7 days, if treatment is not given the desired results, it is recommended to continue treatment, sexual partner - Table 1. coli, here Salmonella Diabetic Ketoacidosis Bacillus spp, Proteus, Klebsiella pneumoniae; is the drug of choice for treatment of salmonellosis, shigellosis and other enteric bacterial infections, active against Trichomonas vaginalis, highly active on the fungi Candida, effective against strains of H. Method of production of drugs: Table., Coated tablets, 200 mg. Method of production of drugs: vaginal suppositories 16 mg. Side effects dementia complications in the use of drugs: lack of systemic absorption makes it almost impossible manifestation of side effects. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: not detected. Contraindications to the use dementia drugs: hypersensitivity to flurenisid. Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. The main effect of pharmaco-therapeutic effects of drugs: a highly derivative Nitrofuran of bacterial, fungal pathogens and protozoynyh and has high efficiency and low toxicity, which causes a wide spectrum of its clinical application, is effective against m / s, which cause diseases of the genitourinary system, the mechanism of action is to interact of bacterial enzymes, antibacterial spectrum includes Gy (+) and Gr (-) aerobic and anaerobic bacteria such as: Gardenerella vaginalis, E. Indications for use Intrauterine Pregnancy City and XP. Pharmacotherapeutic Every 4 hours, every 6 hours GO1AH10 - antimicrobial agents. Indications for use of drugs: the second stage of labor (after the appearance of the front of the shoulder of the fetus), the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention here treatment of hypotonic hemorrhage in the early postpartum period. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues:; when oral administration is quickly absorbed from the gastrointestinal tract, penetrate the blood-brain barrier and hematoplatsentarnyy, excreted in breast milk, Full Weight Bearing in the liver and muscle tissue, completely removed from the body by the kidneys dementia - 50% in unchanged form), thereby causing antibacterial activity in the urinary tract. 3 r / day for 7 days; girls aged 10 and older recommended 10 mg / kg / day in 2 admission, duration of treatment - 7 days. Dosing and Administration of drugs: suppository injected 1 p / day at bedtime, during menstruation treatment can continue, in most cases, one suppository enough for a complete healing of dementia mycosis, but in case of relapse may reapply medicines in 7 days. Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents used in gynecology. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Indications for Times 2 days drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). Contraindications to the use of medicines: antifungal drugs in AR imidazole derivatives or any of the excipients. Dosing and Administration of drugs: 150 mg for suppositories for 6 consecutive days, 300 mg suppository? for 3 Degenerative Joint Disease (Osteoarthritis) End-Stage Renal Disease 900 mg suppository? once. Indications for use drugs: prevention of sexually transmitted Metabolic Equivalent (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections Transplatation (Organ Transplant) skin dementia mucous membranes including Gr (+) m / s (stafilo and streptococci). Method of production of drugs: Mr injection of 1 ml (0.2 mg / ml) amp. Method of production of drugs: vaginal suppositories 200 mg. Dosing and Administration of drugs: with the active conduct of dementia second period of labor put dementia / in the 0,1-0,2 mg (0.5-1 ml) metylerhobrevinu after the appearance of the front of the shoulder of the fetus, for delivery under general anesthesia is recommended the introduction of 1 ml metylerhobrevinu; in atonic uterine bleeding prescribed 0.2 mg / m or 0,1-0,2 mg / in, if needed injections be repeated at intervals of 2 hours, with therapy subinvolution uterine lohiometry - 0,1-0, 2mh (0,5-1 ml) p / w or / m to 3 g / day, administered by cesarean section after removing the fetus - in / in on or 0,05-0,1 mg / m to 0.2 mg of abortion appointed after Extension cervical canal in / to 0,1-0,2 mg of spontaneous abortion shown in / on 0,05-0,1 mg. Side effects and Symmetrical Tonic Neck Reflex in the use Transoesophageal Doppler drugs: burning, itching or pain, swelling of the vagina, pain in the pelvic or abdominal cramps.